Marcus Urey News Today

In July, University of California San Diego Health was the first to offer the therapy used to treat a Hereditary Transthyretin Amyloidosis, which is often fatal.

Numbness and tingling in her feet, heart palpitations, dizzy spells and wrist pain that felt like carpal tunnel syndrome pushed Nancy Kim to confirm that she has the same rare genetic condition that has devastated her family, forcing her father to receive a heart transplant and killing six of her family members.

Drug offers more convenient approach for those with hereditary transthyretin amyloidosis

UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve damage caused by hereditary transthyretin amyloidosis, a rare disease that can be fatal without management.